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Background. South eastern parts of Iran remain endemic for malaria infection. There is some concern that malaria infection
may spread into Bushehr, which is located in the south western part bordering the Persian Gulf and at the periphery of the
declared endemic region Hormozgan province due to frequency of visitors from eastern endemic areas and from neighboring
malaria endemic countries. We investigated malaria prevalence in Bushehr.Methods and Results. Attempts were made to identify
malaria active infection in blood smears and malaria specific antibody and antigens in serum samples. Traditional blood smears
prepared from 1955 blood specimens yielded no definitive malaria positive case by microscopic technique. A total of 270 (13.8%)
serum samples were positive for malaria antibodies. Using specific ELISA kits, presence of histidine rich proteins and lactate
dehydrogenase antigens were investigated in serum samples. No histidine rich proteins specific for P. falciparum were detected
amongst 270 antibody positive samples. However, six samples representing 0.3% of total population, were found to be positive
for plasmodium pan specific lactate dehydrogenase antigens. This suggested the possibility of low level exposure to malaria in
Bushehr community. Conclusions. Out of a total of 1955 samples tested, 270 (13.8%) were positive for malaria antibodies and six
(0.3%) of these were positive for plasmodium-specific lactate dehydrogenase antigen suggesting a low level exposure to malaria in
a hypoendemic region based on immunological testing. Since none of the 270 antibody samples were positive for histidine rich
protein antigens, there is scope for further testing of blood samples by molecular methods such as polymerase chain reactions to
confirm the plasmodium species and provide information valuable for future investigations. Our testing strategy for hypoemdemic
malaria can be used as a template for investing malaria in 32 eliminating countries for testing ongoing transmission.This approach
may be useful as a method in epidemiological studies.
1. Background
Several publications show importance of malaria control and
elimination programs for economic progress [1]. In Iran over
the years, in association with WHO (Roll Back Malaria)
and UNDP programs, considerable amount of effort has
been expended by health authorities to control and prevent
malaria through various measures including residual house
spraying, larvicidal treatment, biological control measures
and community education in using bed nets, and provision
of antimalaria drug therapy [2, 3]. Malaria in Iran has been
recently reviewed [4, 5]. Three provinces (Kerman, Hormoz-
gan, and Sistan-Baluchistan) recorded 16,000 during 2005
to 2007 and following the control measures the incidence
were reduced to just 2166 cases in 2010 [3]. These provinces
share common borders with Afghanistan and Pakistan where
malaria is endemic. Visitors from neighboring endemic
countries come and work temporarily in Iran and they may
bring in infection into new foci. We investigated in some
detail such a possibility in the Bushehr province, which is
located interior to the endemic region and where foreign
workers have access. Investigation was done where external
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Figure 1: Map of Iran and the region where malaria work is
undertaken (marked A and B in the figure). Area B shows the
location of Gaz Refinery where samples were collected. Samples
were transported to area A and tested in this area.
workers from neighboring endemic regions and countries
work in Bushehr province. Our strategy involved using both
traditionalmethods andnovel immunological assays to assess
if malaria was prevalent or not. If prevalent, then the exposed
individuals should show some immunological response to
malaria exposure and at least in the induction of malaria
specific antibodies [6]. Those exposed individuals showing
proven level of malaria antibodies were further tested for
the presence of malaria antigens in the serum samples.
Presence of malaria antigen is suggestive of malaria exposure
in the community. This approach was proved to be useful in
identifying people exposed to malaria.
2. Methods
2.1. Blood Samples. Informed consent was obtained from all
participants and this project was approved by The Persian
Gulf Tropical Medicine Research Center, Bushehr University
of Medical Sciences. Blood samples used in this study were
provided by voluntary individuals who willingly participated
in this study of malaria investigation. The health status
of voluntary blood donors met the required condition as
stipulated by the Ethical committee for using their blood
samples in this investigation. Of the sample donors, none
was suffering from any symptoms suggestive of malaria,
none had ever been hospitalised with malaria. The region
where work was undertaken is marked on themap (Figure 1).
Region A is Bushehr, which is an urban residential locality.
Area B is Asalooyeh which contains both residential and
industrial localities. The Gaz Refinery located in Asalooyeh
attracts several guest workers (designated “travelers”) from
neighboring endemic regions as well as adjacent endemic
countries. Samples fromareaBwere tested in viewof the good
mix of guest workers coming into work at Gaz Refinery as
well as the local residents in area B. The plan of study as well
as the objective of this study in identifying any potential cases
of malaria exposure and/or malaria carriers was explained to
the participants. Altogether a total of 1955 blood samples were
obtained from ten geographically different centers (Table 1).
Specimens were collected during a five-month period from
August to December 2009. OnemL blood samples were
collected into K2-EDTA (ethylenediaminetetraacetic acid
dipotassium salt) tubes for microscopy and other tests. A
second 4mL blood sample was collected in plain tubes and
serum was separated by clotting. Collected specimens were
frozen and stored at –20∘C until tested. Blood films were
prepared from specimens in EDTA tubes.
2.2. Blood Smear Microscopic Examination. Thick and thin
blood smearswere prepared based on the traditionalmethods
described in theMedical Parasitologymanual and other pub-
lications [7, 8]. The blood smears were stained with Giemsa
(MERCK, Germany) and slides were examined under oil
immersion by trained technicians using Olympus Research
Microscope (Cx21). Slides showing proven blood stages of
P. falciparum and P. vivax parasites were used as reference
duringmalariamicroscopy. ForP.malariae andP. ovale, slides
were not available, therefore published pictures were used as
a reference. Cross-checking of slides to confirmdiagnosis was
also performed between technicians.
2.3. Immunoassay for Malaria Antibody. Malaria specific
antibodies present in the serum samples were detected by
using a commercially available ELISA kit (PAN Malaria
Antibody CELISA, Cellabs Pty Ltd, Brookvale NSW, Aus-
tralia). The kit is based on the indirect immunosorbent assay
(ELISA) principle and designed for detection of malaria
specific IgG antibody response in serum against four human
malaria species (Plasmodium falciparum,P. vivax,P.malariae,
and P. ovale). This kit has been independently validated
against other diagnostic methods with (95.5% sensitivity and
92.2% specificity) [9]. ELISA microwells are coated with
a panel of recombinant malaria antigens. Serum samples
are diluted at 1/100 and incubated in the microwells. After
incubation and washing, the wells are incubated with a con-
jugate (mouse anti-human monoclonal antibodies, labeled
with the horse radish peroxidase enzyme). After washing
the wells, a chromogen substrate (tetramethylbenzidine) is
added and incubated, leading to color development which is
proportional to the amount of malaria antibodies present in
the sample. Negative and positive serum controls are supplied
in the kit. A cutoff of OD = 0.150 was developed in our labo-
ratory by using mean (OD = 0.059) + 3SD (SD = 0.0267 × 3)
readings of negative samples. Negative samples were derived
from individuals not exposed to malaria based on travel
history. Test samples were evaluated against this cutoff level
as positive or negative for malaria antibodies. F-test and
Pearson coefficient tests were used to assess any significance
of antibody positivity between 10 centers of blood collection.
2.4. Immunoassay for Malaria Antigens. Histidine rich pro-
teins specific for P. falciparum were detected by using an
ELISA kit (Malaria Antigen CELISA, Cellabs Pty Ltd, Brook-
vale NSW, Australia) [10, 11]
.
Serum samples diluted 1/2 in
International Scholarly Research Notices 3
Table 1:Overall results of PanMalaria antibody andpLDHantigenELISA assays performed onblood samples obtained from 1955 participants
in Bushehr, Iran.
Area1 Number tested2 Antibody positive pLDH antigen positive
Assaloyeh Center 221 (11.30%) 37 (16.74%) 2 (0.90%)
Chah Mobarak Center 187 (9.56%) 39 (20.85%) 1 (0.53%)
Bandare Taheri Center 204 (10.43%) 15 (7.35%) 1 (0.49%)
Nakhle Taghi Center 105 (5.37%) 17 (16.19%) 1 (0.95%)
Ghods Center 366 (18.72%) 65 (17.76%) 1 (0.27%)
17 Shahrivar Center 152 (7.77%) 12 (7.90%) 0.0 (0.0%)
Banak Center 112 (5.72%) 17 (15.18%) 0.0 (0.0%)
PSEEZ-Center1 187 (9.56%) 31 (16.58%) 0.0 (0.0%)
PSEEZ-Center2 331 (16.93%) 24 (7.25%) 0.0 (0.0%)
PSEEZ-Center3 90 (4.60%) 13 (14.44%) 0.0 (0.0%)
Total 1955 (100%) 270 (13.81%) 6 (0.30%)
1Statistical analyses revealed no significant differences in antibody positivity between different centers (𝐹-Test NS) and Pearson coefficient (0.723 NS).
2Microscopy indicated no positive results in the samples tested from 10 centres and also no sample was found to be positive for P. falciparum specific antigens.
PBS/T were tested in the ELISA wells coated with capture
monoclonal antibodies. It is known that detectable levels of
P. falciparum specific HRP antigens are present in serum
[11]. Histidine protein antigens present in the blood sample
were sandwiched by the enzyme labeled detectormonoclonal
antibodies.The amount of sandwiched histidine proteins was
proportional to the color intensity following the addition of a
chromogen substrate into the ELISA wells. The plates were
read in a dual wavelength (450/620 nm) plate reader. The
OD readings of test samples were recorded and compared
to the kit positive (contained natural histidine rich proteins
released by P. falciparum parasites) and negative (media
blank) controls. Any readings above the cutoff level OD> 0.12
(mean + 3SD of negative samples) were classified as positive.
2.5. Immunoassay for Plasmodium Specific Lactate Dehydro-
genase. A second line of testing was performed for cir-
culating plasmodium genus-specific lactate dehydrogenase
(Pan-pLDH-ELISA) antigens in serum samples [12]. Presence
of Pan-pLDH antigens in serum samples is indicative of
active malaria infection. The pLDH CELISA kit [(Cellabs
Pty Ltd, Brookvale NSW, Australia with In-house specificity
(97%) and sensitivity (95%))] assay is based on the capture
of plasmodium-specific lactate dehydrogenase antigens in
serum samples. The kit positive and negative controls pro-
vided a cutoff (mean + 3SD) of OD = 0.100. Any sample
reacting higher than the cutoff was considered positive.
The Pan-pLDH positive samples are suggestive of prevailing
active malaria carriers in the community.
3. Results
3.1. Plan of Study. Theflow chart (Figure 2) details the testing
procedure followed and overall results obtained. Initially
blood smear microscopy was used for identifying active
malaria cases. Both P. falciparum and P. vivax blood smear
positive slides and published blood stage photographs of P.
malariae and P. ovalewere used as reference while examining
the stained smears prepared from a total of 1955 blood
samples. No active malaria cases were identified based on
blood smear microscopy. Then we tested the serum samples
in a validated malaria antibody detection ELISA identifying
sero-positive individuals and malaria antigen ELISAs were
used for identifying individuals carrying malaria. Results of
microscopy, antibody, and antigen levels that were found in
10 different centers are documented in Table 1. No significant
difference was seen in the antibody positivity between 10
different centers (Table 1) (F-test andPearson coefficient test).
3.2. Participants. Of the 1955 individuals enrolled for the
study, a total of 1085 (55.5%) were men and 870 (44.5%)
were women. The mean age was 32.82 ± 14.61 years. There
were 1422 local residents and 533 travelers. About 5mL blood
samples were collected from each volunteer by venipuncture,
and the whole blood was stored at 4C in the refrigerator until
use in the assays. Serum samples were frozen at −20C until
use. Travelers were also included in this study for testing the
possibility of them bringing active malaria infection from
endemic into nonendemic regions. All samples from local
residents as well as from travelers were tested under identical
condition for prevailing malaria antibodies as well as for
malaria antigens.
3.3. Testing for Malaria Antibodies and Antigens. PanMalaria
IgG antibody test was employed. The kit positive control
reacted fairly strongly (meanOD= 2.581) which is 44x higher
than theOD reading of the negative control.This showed that
PanMalaria antibody kit possesses a high level (>40x) of dis-
crimination between negative and positive samples. A battery
of in-house negative samples plus kit negative control samples
were initially tested and a cutoff (mean + 3SD) (OD = 0.150)
was determined. This cutoff served as the basis for differ-
entiating positive samples in malaria antibody assay. In a
similar manner we also developed a cutoff level for malaria
antigen ELISAs. Data in Table 1 shows that out of 1955 blood
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Figure 2: Flow chart and overall results.
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Figure 3: Frequency distribution of OD readings of 1955 serum samples tested at 1/100 dilution in Pan Malaria IgG CELISA. The samples
(𝑛 = 270) showing OD readings >0.150 are regarded as positive.
samples tested 270 samples reacted formalaria antibodies and
6 samples reacted for malaria antigens.
3.4.MalariaAntibodyAssay - FrequencyDistribution of ELISA
Absorbance Value. Out of a total of 1955 samples tested in Pan
Malaria IgG antibody CELISA (see frequency distribution
of OD readings in Figure 3), 270 samples (13.8%) reacted
positively formalaria antibodies. A cutoff (mean+ 3SD)OD=
0.150 was used to identify positively reacted samples. Figure 4
shows intensity of OD readings above the cutoff; 11.1% of
local resident samples and 21% of traveler samples reacted
positively in the antibody assay (Figure 4). Bushehr region
therefore contained local residents with malaria antibodies
which are suggestive of their exposure to malaria infection.
The origin of their malaria exposure is beyond the scope of
this investigation.The premise that travelers were the cause of
local infection in Bushehr was further investigated by using
plasmodium antigen specific assays.
3.5. Exposure to Malaria Significantly Influenced by Age.
Data based on age are shown in Table 2; highest rates of
seropositivity were seen in two age groups (i.e., 21–30 and 31–
40).
3.6. Testing for P. falciparumCases. Malaria antibody positive
serum samples were tested for presence of P. falciparum
specific histidine rich protein antigens in serum samples by
using a commercial kit proven to be highly sensitive for
detecting P. falciparum cases [10, 11]. None of the antibody
positive samples tested were found to be positive (cutoff
OD = 0.12) for P. falciparum antigen. This showed that no
P. falciparum carriers were present in the malaria antibody
positive samples based on histidine rich protein ELISA [10].
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Figure 4: Scattergram of 270 malaria antibody positive samples OD = 0.15.
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Figure 5: Comparative levels of malaria antibody and pLDH antigens in six samples.
3.7. Pan-pLDH Assay for Identification of Active Malaria
Carriers. Next, a total of 270 antibody positive samples were
further tested in plasmodium specific lactate dehydrogenase
ELISA test (Pan-pLDHassay cut off (mean+ 3SD;OD=0.10);
6 antibody positive samples (PS) (PS numbers 43, 94, and 107
from residents samples andPSnumbers 161, 172, and 230 from
travelers samples) reacted positively in pLDH antigen assay
(Figure 5). When we referred back to their malaria antibody
levels, PS numbers 43 and 172 showed elevated antibody
readings, respectively (OD = 3.679, 2.023) and the latter
also showed elevated pLDH level. The three pLDH positive
samples were derived from the travelers from endemic Sistan
(PS number 161) and Hormozgan (PS numbers 172 and
230) provinces. Blood smears from six Pan-PLDH antigen
positives were reexamined microscopically and none were
positive.
4. Discussion and Conclusions
The national malaria control programs initiated in Iran
during the 1950’s resulted by 1977 [2–4] in the eradication
of infection from the Caspian Sea region in the north and
in the south, a substantial reduction in transmission in
the coastal plains along the Persian Gulf. Malaria was then
restricted to the southeastern provinces of Hormozga, Sistan,
and Baluchistan and the tropical region of Kerman. However,
due to displacement of people from neighboring countries,
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Table 2: The range of age groups of participants and overall percentages of antibody positives seen when serum samples were tested in Pan
Malaria antibody ELISA.
Age (range) of
participants
Number of antibody
positives/total number tested
Age group percentage
(positivity)
Overall percentage
(positivity)
<11 years 3/38 7.9% 0.15%
11–20 20/216 9.2% 1%
21–30 116/670 17.3% 5.93%
31–40 92/583 15.8% 4.7%
41–50 18/264 6.8% 0.92%
51–60 7/105 6.7% 0.36%
>61 14/79 17.7% 0.72%
Total (overall
percentage) 270/1955 13.8%
malaria reemerged in Iran [13]. Recent review on endemic
infectious diseases in Afghanistan points towards possible
impact of malaria in adjacent countries and that impact may
occur through a guest worker (traveller) coming into Iran
[14]. The Bushehr region, being in the southwest, is out of
the declared endemic south east regions. Our investigation
mainly focused in locating possible active carriers, if any, in
the hypoendemic Bushehr region. Our main purpose was to
identify individuals potentially exposed to malaria, as they
may harbour infection and become a source for transmission
within a region. Our purpose was first to identify individuals
showing malaria antibodies in serum as an evidence for
exposure. Then samples from those malaria antibody pos-
itive individuals were further tested for circulating malaria
antigens by antigen capture ELISA [15]. The lack of positive
blood smears amongst a total of 1955 blood samples tested by
malariamicroscopy indicated no evidence for clinicalmalaria
cases in the Bushehr community.
We subsequently focused our investigation towards iden-
tifying those individuals exposed to malaria. It is known
that antibodies prevail in the circulation for many years after
exposure to malaria infection [6]. It is also known that the
presence of malaria specific antibody in the serum is helpful
in determining if a particular individual has been exposed
to the malaria or not. Out of 1955 serum samples tested,
270 samples were found to be positive (OD > 0.150) for
malaria specific antibodies. 21% of traveler samples reacted
positively for antibodies as opposed to 11% of local residents
samples. Based on our Giemsa methodology none were
showing active malaria infection. We recorded relatively
higher percentage of antibody response in certain age groups
(21 to 40) (Table 2). This antibody positivity is based upon
the sensitivity and specificity of the assay we employed.
The Pan Antibody positivity was determined by the Pan
Malaria Antibody assay, an assay that has been independently
shown to have high specificity and sensitivity [9], so we
believe our results to be reliable and acceptable. It sug-
gests the current situation prevailing in the community. On
the whole, only a small proportion of the general population
was found to be positive for malaria antibody response.
However, a large part of the study population (86%) did not
have any indication of seropositivity. We therefore conclude
that malaria in Bushehr region is not alarming. In support of
this statement, we did not find any evidence for P. falciparum
active infection amongst the exposed group of 270 samples,
with sensitive and well validated histidine rich proteins
ELISA tests that have been used with field malaria samples
[10, 11]. Utility of histidine rich proteins and parasite lactate
dehydrogenase tests is well documented [10–12].
We further tested those malaria antibody positives with
the pLDH CELISA kit to detect plasmodium specific lactate
dehydrogenase enzyme. Six individuals were found to be
positive at a very low level of pLDH. Because the P. fal-
ciparum specific histidine rich proteins ELISA results were
consistently negative, it is reasonable to assume that these
six individuals may have been exposed to non-falciparum
malaria species.
A point of explanation is needed on our results. Here
our observation has shown only the “exposure” situation and
not as any degree of “infection.” It is assumed that Bushehr
community is naive to malaria. It is postulated that malaria
is introduced into Bushehr by a traveller from an adjacent
malaria endemic area, and that results in local transmission.
Our findings substantiate this situation very well as Giemsa-
based blood smear microscopy was consistently negative
and no active malaria case was observed. Results can be
attributed only as “exposure” situation but not as “infection”
situation in Bushehr. If we see overall malaria antigen results,
it is clearly apparent that absence of histidine proteins
shows there is no active infection prevailing. However in
absence of histidine proteins, occurrence of pLDH in some
of the individuals may show that they may carry some sub-
microscopic stages of P. vivax invariably in the form of
dormant hypnozoites [16, 17]. Hypnozoites persists for a long
period of time and may be source of additional infections in
the hypo-endemic sites. The role of hypnozoites as dormant
parasites is very well established in US war veterans. This
may be the case in Bushehr where no active infections
shownbut pLDH indicated the possibility of sub-microscopic
infection.
Because we restricted antigen testing only to antibody
positive samples, a question may be raised on the pos-
sibility of antibody negative samples showing some level
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of antigens. This criticism can be answered by stating
that, if malaria is endemic in the community, then such
antigen positive individuals should have tested positive
for malaria antibodies, because malaria antibodies develop
soon after infection. It is unlikely that antibody nega-
tive individuals would be positive for malaria antigens.
We, therefore, conclude that our approach of only test-
ing for malaria antigen in antibody positive individuals is
appropriate.
Recently P. vivax and P. falciparum have been reported
from central Iran, aside from known records of infection
from southeastern endemic regions [18, 19]. There is also a
clear indication of two prevailing species (P. vivax in 94%
cases and P. falciparum in 6% cases) in Iran. Despite a recent
report of a malaria slide positivity rate of 1.19% in Iran [19],
we did not record a single case of infection by blood smear
microscopy in the Bushehr province. However, we should
point out that our conclusions are based on the results that
came out of the immunological assays we have employed
during this study. It is quite possible that inclusion of other
tools such as polymerase chain reaction may be useful in
generating additional information. This is planned for future
studies.
Our work has shown the usefulness of immunoassays in
identifying individuals exposed tomalaria and also in detect-
ing individuals carrying potentially active infections albeit at
a possibly low level parasitaemia that are not detectable by
Giemsa microscopy. Asymptomatic malaria in hypoendemic
areas is very important [20, 21]. This strategy of testing we
followed here at Bushehr may be useful for indentifying
asymptomatic malaria exposure in 34 malaria-eliminating
countries.
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